The California Institute for Regenerative Medicine (CIRM) welcomes a distinguished group of new board members and alternates, each bringing a wealth of experience and leadership in healthcare, research, and innovation. Joyce A. Sackey, MD, FACP Dr. Sackey joins CIRM as an alternate for Linda Boxer. As the inaugural Chief Equity, Diversity, and Inclusion Officer at … Continue reading CIRM Welcomes New Board Members
CIRM
CIRM’s Key Recommendations from Strategic Allocation Framework
The California Institute for Regenerative Medicine (CIRM) presented key recommendations from its Strategic Allocation Framework (SAF), offering a structured, data‑driven approach to guide funding decisions and maximize impact. These recommendations, shared with the Independent Citizens’ Oversight Committee, move CIRM closer to its mission to accelerate the development and delivery of innovative regenerative medicine therapies. Evolving … Continue reading CIRM’s Key Recommendations from Strategic Allocation Framework
Strategic Framework Impacts the Future of CIRM’s Research Funding
As the regenerative medicine field rapidly evolves, CIRM faces a key challenge: investing the remaining $3.86 billion in ways that deliver the greatest impact for Californians. To meet this challenge, CIRM launched the Strategic Allocation Framework (SAF) to prioritize resources and maximize the potential of regenerative medicine breakthroughs. What is the SAF? The SAF uses … Continue reading Strategic Framework Impacts the Future of CIRM’s Research Funding
A new generation in the golden era of regenerative medicine
CIRM CEO and President, Jonathan 'JT' Thomas, speaking in front of conference attendees. At this year's California Institute for Regenerative Medicine Trainee Networking Conference, the young scientists assembled heard it loud and clear: this is the time, and California is the place for regenerative medicine. “You’re in the golden era of biomedical innovation,” said CIRM … Continue reading A new generation in the golden era of regenerative medicine
Where Are They Now: Jake Javier
On the first day, of the 2024 CIRM Trainee Network Conference, Jake Javier took shared his experience as a clinical trial patient, as how he benefited from the innovative trial. The event done in partnership with the University of Southern California (USC) gave trainees from CIRM’s education and training programs an opportunity to engage with … Continue reading Where Are They Now: Jake Javier
Meet Our New CEO: Jonathan Thomas
We are excited to reintroduce Jonathan Thomas (JT) as the new President and CEO of the California Institute for Regenerative Medicine. You can read the original press release here. We recently spoke with JT, who previously served as Chair of the Independent Citizens’ Oversight Committee and as interim President and CEO. He discussed what excites … Continue reading Meet Our New CEO: Jonathan Thomas
A CIRM Bridges Trainee’s Path into Regenerative Medicine
Josh Nelson, a former technical director for various theaters, tapped into CIRM's Bridges program at Cal Poly Humbolt to establish a career in regenerative medicine research.
Gene therapy trial tests cancer-killing virus in brain tumors
Dr. Noriyuki Kasahara of UCSF has received $11.8 million from CIRM to target newly diagnosed high‑grade gliomas. These aggressive brain and spinal cord cancers are extremely hard to treat. The grant supports research on DB107, formerly Toca 511, an innovative gene therapy that selectively targets tumor cells. The therapy delivers an enzyme that converts a … Continue reading Gene therapy trial tests cancer-killing virus in brain tumors
CIRM awards $6 million to advance research for heart attack and heart failure treatments
Arjun Deb, MD, a UCLA professor of medicine and biology, received a $6 million award from CIRM to advance his research on heart attack and heart failure treatments. Cardiovascular disease is the leading global cause of death, responsible for about one-third of all deaths. A heart attack causes permanent heart muscle damage and often leads … Continue reading CIRM awards $6 million to advance research for heart attack and heart failure treatments
CIRM Welcomes Jonathan Thomas as New President and CEO
The California Institute for Regenerative Medicine (CIRM) announces Jonathan “JT” Thomas, PhD, JD, as its new President and CEO. JT brings broad experience and a strong commitment to CIRM’s mission. He previously served 12 years as Chair of the Independent Citizens' Oversight Committee (ICOC) and most recently as Interim CEO. “JT understands our mission and … Continue reading CIRM Welcomes Jonathan Thomas as New President and CEO